This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Melanson, S. E.F. Articles by Jarolim, P. Search for Related Content PubMed PubMed Citation Articles by Melanson, S. E.F. Articles by Jarolim, P. Related Collections Biochemistry and metabolism Acute coronary syndromes Other diagnostic testing Acute myocardial infarction

(Circulation. 2007;116:e501-e504.)
© 2007 American Heart Association, Inc.

Clinician Update

Cardiac Troponin Assays

A View From the Clinical Chemistry Laboratory

Stacy E.F. Melanson, MD, PhD; Milenko J. Tanasijevic, MD, MBA; Petr Jarolim, MD, PhD

From the Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass.

Correspondence to Petr Jarolim, MD, PhD, Brigham and Women’s Hospital, 75 Francis St, Amory 2, Boston, MA 02115. E-mail pjarolim@partners.org

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
Many clinical chemistry laboratories perform troponin testing to aid in the diagnosis of acute coronary syndrome (ACS). Laboratories must interact with clinicians to establish diagnostic cut points, achieve acceptable assay performance, and troubleshoot questionable findings. Here we present 3 hypothetical scenarios related to troponin testing in the clinical chemistry laboratory.

	Troponin: Its Utility in Acute Coronary Syndrome

 
Case Presentation 1: J.P. is an obese 55-year-old male with a history of gastroesophageal reflux disease who presents to the emergency department with substernal chest pain that he attributes to a "large meal." J.P. is pale and diaphoretic. An ECG shows tachycardia with normal sinus rhythm. J.P.’s troponin levels (decision limit >0.04 µg/L) at presentation and at 6 and 12 hours after presentation are 0.09, 4.41, and 19.62 µg/L, respectively.

	Performance and Analytical Accuracy of Troponin Assays

 
Cardiac troponin (cTn) has established itself firmly as the "gold standard" in the diagnosis of ACS. cTn should be measured in all patients presenting with symptoms suggestive of ACS, in conjunction with physical examination and ECG.¹ Because of the specificity of cTn for myocardial damage, a single cTn above the decision limit, along with clinical evidence, is indicative of myocardial injury. However, serial testing can be useful, depending on clinical presentation and onset of symptoms.

cTn is a protein complex, located along the thin filaments of myofibrils, that regulates the contraction of cardiac muscle. It is composed of 3 distinct gene products. cTnC binds calcium, cTnT attaches to tropomyosin on thin filaments, and cTnI inhibits actomyosin ATPase. Expression of each subunit is cardiac restricted. The cardiac isoforms of cTnI and . . . [Full Text of this Article]

This article has been cited by other articles:

				H. Keshishian, T. Addona, M. Burgess, D. R. Mani, X. Shi, E. Kuhn, M. S. Sabatine, R. E. Gerszten, and S. A. Carr Quantification of Cardiovascular Biomarkers in Patient Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution Mol. Cell. Proteomics, October 1, 2009; 8(10): 2339 - 2349. [Abstract] [Full Text] [PDF]

				A. Mingels, L. Jacobs, E. Michielsen, J. Swaanenburg, W. Wodzig, and M. van Dieijen-Visser Reference Population and Marathon Runner Sera Assessed by Highly Sensitive Cardiac Troponin T and Commercial Cardiac Troponin T and I Assays Clin. Chem., January 1, 2009; 55(1): 101 - 108. [Abstract] [Full Text] [PDF]

				R. P. Giugliano and E. Braunwald The Year in Non-ST-Segment Elevation Acute Coronary Syndrome J. Am. Coll. Cardiol., September 23, 2008; 52(13): 1095 - 1103. [Full Text] [PDF]